Upgrade to SI Premium - Free Trial

Mylan's (MYL) Biosimilar to Roche's Herceptin Wins FDA Approval

December 1, 2017 10:46 AM
(Updated - December 1, 2017 10:48 AM EST)The U.S. Food and Drug Administration today approved Ogivri (trastuzumab-dkst) as a biosimilar ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA Hot Corp. News Hot FDA News Trader Talk

Next Articles